Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001096906-10-001251
Filing Date
2010-10-04
Accepted
2010-10-01 20:54:05
Documents
5
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 AOXING PHARMACEUTICAL COMPANY, INC. FORM 10-K JUNE 30, 2010 axn10k20100630.htm 10-K 1103465
2 CERTIFICATE OF INCORPORATION, AS AMENDED TO DATE axn10k20100630ex3-a.htm EX-3.A 126819
3 RULE 13A-14(A) CERTIFICATION - ZHENJIANG YUE axn10k20100630ex31-1.htm EX-31.1 9469
4 RULE 13A-14(A) CERTIFICATION - HUI SHAO axn10k20100630ex31-2.htm EX-31.2 9618
5 RULE 13A-14(B) CERTIFICATION axn10k20100630ex32.htm EX-32 5174
  Complete submission text file 0001096906-10-001251.txt   1256380
Mailing Address 15 EXCHANGE PLACE, SUITE 500 JERSEY CITY NJ 07302
Business Address 15 EXCHANGE PLACE, SUITE 500 JERSEY CITY NJ 07302 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-32674 | Film No.: 101103862
SIC: 2834 Pharmaceutical Preparations